Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester

Request For Quotation
Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:HSD17B13-IN-38
CAS:2730022-56-5
Package:50mg/RMB 13800
Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester Basic information
Product Name:Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester
Synonyms:Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester;HSD17B13-IN-38
CAS:2730022-56-5
MF:C22H19N3O3
MW:373.4
EINECS:
Product Categories:
Mol File:2730022-56-5.mol
Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester Structure
Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester Chemical Properties
Boiling point 599.4±60.0 °C(Predicted)
density 1.23±0.1 g/cm3(Predicted)
pka3.44±0.10(Predicted)
Safety Information
MSDS Information
Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester Usage And Synthesis
UsesHSD17B13-IN-38 (Compound D) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13). HSD17B13-IN-38 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH[1].
References[1] Vincent FLORIO, et al. Substrate selective hsd17b13 inhibitors and uses thereof. WIPO, WO2021211981A1. 2021-10-21.
Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester Preparation Products And Raw materials
Tag:Benzoic acid, 3-[5-methoxy-2-(4-pyridinyl)-1H-benzimidazol-1-yl]-, ethyl ester(2730022-56-5) Related Product Information
2-Thiophenecarboxamide, 3-[(3-chloro-4-hydroxybenzoyl)amino]-N-[2-(2-methoxyphenyl)ethyl]- 6-BROMOCOUMARIN 3-(3,4-Dihydroisoquinolin-2(1H)-ylsulphonyl)benzoic acid FXRHSD17B13 modulator 1 3-((4-(TrifluoroMethyl)phenyl)aMino)benzoic acid HSD17B13-IN-43